Literature DB >> 31056316

In vitro maturation rates in young premenarche patients.

Gilad Karavani1, Natali Schachter-Safrai2, Ariel Revel3, Talya Mordechai-Daniel3, Dvora Bauman2, Tal Imbar3.   

Abstract

OBJECTIVE: To evaluate in vitro maturation (IVM) efficacy and oocyte retrieval rates after ovarian tissue cryopreservation in young premenarche girls facing chemo- and radiotherapy.
DESIGN: A retrospective cohort study.
SETTING: University-affiliated tertiary medical center. PATIENT(S): A total of 84 chemotherapy-naïve patients ages 0-18 years referred for fertility preservation between 2004 and 2017: 33 premenarche and 51 postmenarche patients. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): IVM in the pre- and postmenarche groups and in the subgroups of very young (up to age 5 years) and older (5-10 years) premenarche girls.
RESULTS: The number of oocytes retrieved did not significantly differ between the postmenarche and premenarche groups (10.8 ± 8.5 and 8.1 ± 6.8, respectively). However, the overall IVM rate was significantly higher in the postmenarche group (28.2% vs. 15.5%, respectively; odds ratio = 0.47). A separate analysis for patients up to 5 years of age demonstrated significantly lower oocyte yield compared with the older (5-10 years) premenarche girls (4.7 ± 5.2 vs.10.3 ± 7.0 oocytes, respectively) and much lower IVM rates (4.9% and 18.2%, respectively). Correlation of age with number of retrieved and matured oocytes showed a positive significant correlation (r = 0.45 and r = 0.64, respectively).
CONCLUSIONS: IVM performed after ovarian tissue cryopreservation in premenarche girls and specifically in very young girls (4 years and younger) yields substantially decreased maturation rates compared with postmenarche patients, raising a question as to the utility of current IVM technique in this age group. Further studies are required to assess modification of the IVM technique for young girls.
Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In vitro maturation; chemotherapy; fertility preservation; ovarian tissue cryopreservation; premenarche

Mesh:

Substances:

Year:  2019        PMID: 31056316     DOI: 10.1016/j.fertnstert.2019.03.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Two novel mutations in exon 2 of bone morphogenetic protein (BMP) 15 gene in Pakistani infertile females.

Authors:  Hafiza Faiza; Majida Khan; Muhammad Rafiq; Anoshiya Ali Khan; Nadir Ali Rind; Syed Habib Ahmed Naqvi
Journal:  Saudi J Biol Sci       Date:  2021-05-29       Impact factor: 4.219

2.  A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation.

Authors:  Ashley A Diaz; Hana Kubo; Nicole Handa; Maria Hanna; Monica M Laronda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

3.  Maternal Smc3 protects the integrity of the zygotic genome through DNA replication and mitosis.

Authors:  Wei-Ting Yueh; Vijay Pratap Singh; Jennifer L Gerton
Journal:  Development       Date:  2021-12-22       Impact factor: 6.868

4.  Case report: two cases of mature oocytes found in prepubertal girls during ovarian tissue cryopreservation.

Authors:  Sarina N Hanfling; Toral Parikh; Allison Mayhew; Erin Robinson; James Graham; Veronica Gomez-Lobo; Jacqueline Y Maher
Journal:  F S Rep       Date:  2021-04-08

5.  Twenty-first century oocyte cryopreservation-in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review.

Authors:  Ahmad Mohd Faizal; Yodo Sugishita; Yuki Suzuki-Takahashi; Hideyuki Iwahata; Seido Takae; Yuki Horage-Okutsu; Nao Suzuki
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

6.  Age-Dependent in vitro Maturation Efficacy of Human Oocytes - Is There an Optimal Age?

Authors:  Gilad Karavani; Peera Wasserzug-Pash; Talya Mordechai-Daniel; Dvora Bauman; Michael Klutstein; Tal Imbar
Journal:  Front Cell Dev Biol       Date:  2021-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.